Skip to main content
Pain Research & Management logoLink to Pain Research & Management
. 2009 Jul-Aug;14(4):299–305. doi: 10.1155/2009/468321

Alexithymia and fear of pain independently predict heat pain intensity ratings among undergraduate university students

Joel Katz 1,2,, Andrea L Martin 1, M Gabrielle Pagé 1, Vincent Calleri 2
PMCID: PMC2734517  PMID: 19714270

Abstract

BACKGROUND:

Alexithymia is a disturbance in awareness and cognitive processing of affect that is associated with over-reporting of physical symptoms, including pain. The relationship between alexithymia and other psychological constructs that are often associated with pain has yet to be evaluated.

OBJECTIVES:

The present study examined the importance of alexithymia in the pain experience in relation to other integral psychological components of Turk’s diathesis-stress model of chronic pain and disability, including fear of pain, anxiety sensitivity, pain avoidance and pain catastrophizing.

METHODS:

Heat pain stimuli, using a magnitude estimation procedure, and five questionnaires (Anxiety Sensitivity Index, Fear of Pain Questionnaire III, Pain Catastrophizing Scale, avoidance subscale of the Pain Anxiety Symptoms Scale-20 and Toronto Alexithymia Scale-20) were administered to 67 undergraduate students (44 women) with a mean (± SD) age of 20.39±3.77 years.

RESULTS:

Multiple linear regression analysis revealed that sex, fear of pain and alexithymia were the only significant predictors of average heat pain intensity (F[6, 60]=5.43; R2=0.35; P=0.008), accounting for 6.8%, 20.0% and 9.6% of unique variance, respectively. Moreover, the difficulty identifying feelings and difficulty describing feelings subscales, but not the externally oriented thinking subscale of the Toronto Alexithymia Scale-20 significantly predicted average heat pain intensity.

CONCLUSIONS:

Individuals with higher levels of alexithymia or increased fear of pain reported higher average pain intensity ratings. The relationship between alexithymia and pain intensity was unrelated to other psychological constructs usually associated with pain. These findings suggest that difficulties with emotion regulation, either through reduced emotional awareness via alexithymia or heightened emotional awareness via fear of pain, may negatively impact the pain experience.

Keywords: Alexithymia, Fear of pain, Heat pain stimulation, Pain intensity, Undergraduates


Over the past decade, alexithymia and its relationship to pain has become a focus of intense research. Alexithymia is a multidimensional construct (1,2) that refers to cognitive and emotional disturbances (3) characterized by four attributes – problems recognizing and explaining emotions, problems distinguishing between emotional and physical sensations, restricted imagination, and externally focused and concrete cognitive style (35).

Research has shown that patients with chronic pain have higher levels of alexithymia than healthy controls, and alexithymia is associated with over-reporting physical symptoms (eg, somatic complaints, anxiety, and hypochondriasis) (6). Research conducted on healthy subjects has also demonstrated an association between alexithymia and increased pain intensity and sensitivity in laboratory studies of experimentally induced pain (79) and in a community sample of individuals undergoing venipuncture for blood donation (10).

Results from these studies highlight the importance of alexithymia in the pain experience. However, most research examining pain and alexithymia has been conducted in isolation from other psychological factors (1113) recognized as integral to the pain experience. Research supports the importance of anxiety sensitivity (14,15), fear of pain and pain anxiety (1619), pain avoidance (20,21), and pain catastrophizing (22,23) in the expression of pain and pain-related disability. These constructs have been the focus of recent models of pain, such as the diathesis-stress model of chronic pain and disability (24).

According to this model (24), individuals who are high in anxiety sensitivity (diathesis) and who are exposed to a painful trauma or event (stress) are likely to develop chronic pain and disability through well-articulated cognitive and emotional processes involving fear and avoidance (eg, fear of pain, catastrophizing, self-efficacy, and escape-avoidance) (25). Despite the growing body of research demonstrating the relationship between alexithymia and pain, there is very little integration of these findings with existing models of pain, such as Turk’s diathesis-stress model (24). An exception is the study by Lumley et al (26), which examined the relationship between alexithymia, self-efficacy, catastrophizing, depression, and pain severity and impairment in patients with chronic myofascial pain. Alexithymia showed a moderate to strong correlation with self-efficacy, catastrophizing, and depression, and was also associated with pain affect and impairment, but not with pain sensitivity (26).

The objective of the current study was to examine the relationship between alexithymia and integral components of the pain experience highlighted in Turk’s diathesis-stress model of chronic pain and disability (24). The relationships among alexithymia, fear of pain, anxiety sensitivity, pain avoidance, catastrophizing, sex, and heat pain intensity were assessed in a sample of undergraduate university students.

METHODS

Participants

The study sample comprised 67 undergraduate students (44 women and 23 men) 17 to 45 years of age, who had a mean (± SD) age of 20.39±3.77 years, and were proficient in English. Individuals received course credit for their participation.

Heat pain stimuli and subjective pain ratings

Thermal stimuli were delivered using a Peltier thermode with a skin contact surface of 16 mm2 (TSA-III NeuroSensory Analyzer; Medoc Ltd, Israel). This computerized device is capable of generating heat or cold stimuli that range from approximately 0°C to 50°C. Pressing a button stops the rise or drop in temperature and the thermode rapidly returns to room temperature at a rate of 10°C/s. Even at the extreme high (50°C) and low (0°C) temperatures, the thermode does not damage the skin, although participants may temporarily feel sensitive at the site where the thermode is applied.

The contact thermode was applied to the ventral aspect of the participant’s nondominant forearm and affixed in place with a Velcro strap (Velcro USA Inc). Consistent with previous work in magnitude estimation of thermal stimuli (27), four suprapain threshold heat stimuli (46°C, 47°C, 48°C, and 49°C) were administered in random order. All trials began at a baseline temperature of 32°C, increased at a rate of 4°C/s and remained at the preset peak temperature for a duration of 5 s. A 30 s interval was maintained between successive stimuli to avoid sensitization of cutaneous receptors. During the 5 s period when the thermode reached its peak temperature, participants were asked to rate the intensity of the pain they experienced on a numerical rating scale (NRS) ranging from no pain at all (0) to the most intense pain imaginable (100). These temperatures were selected to be consistent with previous work (27) and to ensure that these stimuli were above the mean heat pain threshold (as previously established in these subjects; data not shown).

Questionnaires

Anxiety Sensitivity Index:

The Anxiety Sensitivity Index (ASI) (28) is a widely used, 16-item scale that measures concerns that anxiety and anxiety-related symptoms will lead to harmful negative consequences. Each item is rated on a five-point scale ranging from 0 (very little) to 4 (very much). The ASI yields a total score and three factor analytic-derived sub-scale scores, including fear of somatic symptoms/physical concerns, fear of cognitive symptoms/mental incapacitation concerns, and fear of publicly observable symptoms/social concerns (29). The ASI demonstrates good test-retest reliability (r=0.72) and research demonstrates some evidence for the discriminant validity of the three subscales among anxiety disorder outpatients (30). The internal consistency of the ASI in the present study was excellent (alpha = 0.87).

Pain Catastrophizing Scale:

Pain catastrophizing is characterized by unrealistic beliefs that the current situation will lead to the worst possible pain outcome (31), negative thoughts about the future and self (24), and “an exaggerated negative ‘mental set’ brought to bear during actual or anticipated pain experience” (32). The Pain Catastrophizing Scale (PCS) (33) consists of 13 items describing thoughts and feelings that individuals may experience when they are in pain. Each item is rated on a five-point scale ranging from 0 (not at all) to 4 (all the time). The PCS yields a total score and three subscale scores assessing rumination, magnification, and helplessness. The PCS demonstrates adequate to excellent internal consistency in community (alpha = 0.88 to 0.95) and pain outpatient samples (alpha = 0.75 to 0.92) (34). The PCS has moderate convergent validity; the correlation coefficient between the PCS and a self-report measure of anxiety is r=0.32 and negative affectivity is r=0.70 (33). The PCS shows good test-retest reliability at six (r=0.75) and 10 (r=0.70) weeks (33). The internal consistency of the PCS in the present study was excellent (alpha = 0.92).

Pain Anxiety Symptoms Scale-20:

The Pain Anxiety Symptoms Scale-20 (PASS-20) (35) is a shortened 20-item version of the original 40-item PASS (36) designed to assess fear and anxiety responses specific to pain. The PASS-20 consists of four five-item subscales, including cognitive anxiety responses, escape and avoidance, fearful thinking, and physiological anxiety responses. Each item is rated on a six-point scale ranging from 0 (never) to 5 (always), with total scores ranging from 0 to 100. The PASS-20 has been shown to have good internal consistency (alpha = 0.81) and good convergent validity with the original 40-item PASS (r=0.95) (35). Concurrent validity of the PASS-20 is demonstrated through its moderate to high correlations with related measures such as anxiety sensitivity (ASI; r=0.56), fear of pain (Fear of Pain Questionnaire III [FPQ-III]; r=0.53), and pain catastrophizing (PCS; r=0.38) (37). The internal consistency of the PASS-20 in the present study was excellent (alpha = 0.93). Consistent with previous research (38,39), the escape and avoidance sub-scale of the PASS-20 (PASS-AVO) was used as a measure of pain avoidance.

FPQ-III:

The FPQ-III (40) is a 30-item self-report measure designed to assess fear of pain in nonchronic pain populations. The FPQ-III assesses fear of severe pain, fear of minor pain, and fear of procedural pain due to medical interventions. Each item is rated on a five-point scale ranging from 1 (not at all) to 5 (extreme). The FPQ-III has good internal consistency (alpha = 0.88 to 0.92) and test-retest reliability (r=0.69 to 0.74) at three-week follow-up (40). Furthermore, high fear of pain scores correlate significantly with avoidance/escape behaviour during a pain-relevant Behavioral Avoidance Test, suggesting predictive validity (40). The internal consistency of the FPQ-III in the present study was excellent (alpha = 0.89).

Toronto Alexithymia Scale-20:

Alexithymia is a construct that describes a personality style characterized by deficits in the subjective awareness and cognitive processing of affect (41). The Toronto Alexithymia Scale-20 (TAS-20) (42) is a 20-item self-report inventory that measures three dimensions of alexithymia – difficulty identifying feelings, difficulty describing feelings, and externally oriented thinking. Each item is rated on a five-point scale ranging from 1 (strongly disagree) to 5 (strongly agree). Total TAS-20 scores range from 20 to 100. The TAS-20 demonstrates good internal consistency (alpha = 0.70 to 0.86) (43) and test-retest reliability (r=0.77) over a three-week period (42). The internal consistency of the TAS-20 in the present study was good (alpha = 0.80).

NRS for pain intensity:

Pain intensity in response to the four heat pain stimuli was measured using a self-report NRS (44). The NRS consists of a series of numbers ranging from 0 (‘not at all’) to 100 (‘the most pain imaginable’). Participants were asked to choose the number that best corresponded to the intensity of each heat pain stimulus. The NRS is commonly used in clinical settings (45) and is the preferred pain rating scale among patients (46). The NRS is highly correlated (r=0.94) with the visual analogue scale (45) and is sensitive to change following pharmacological interventions (44).

Procedure

The research study was reviewed and approved by the Human Participants Review Committee at York University (Toronto, Ontario). Following informed written consent, participants underwent thermal sensory testing and completed the ASI, PCS, PASS-20, FPQ-III, and TAS-20. The order of administration of questionnaires was randomized within participants. The order of thermal testing and questionnaire completion was counterbalanced across participants such that one-half of the participants underwent thermal testing and then completed the questionnaires, and the other one-half completed the questionnaires followed by the thermal testing.

RESULTS

Descriptive statistics

Means and SDs of each score are presented on the main diagonal of Table 1. Scores on the TAS-20, PCS, PASS-AVO, and FPQ-III were similar to those obtained in large community samples. Ten per cent of participants (n=7) in the present study had scores on the TAS-20 above the cut-off score of 61 or greater that corresponds with clinical levels of alexithymia (47). Scores on the ASI were higher compared with scores obtained in other community samples (eg, mean ASI score 21.85±10.14 in reference 48). Correlations between average pain intensity across the four heat pain stimuli, anxiety sensitivity, fear of pain, pain catastrophizing, pain avoidance, alexithymia, and sex are presented in Table 1. Pain catastrophizing, pain avoidance, and sex were not significantly correlated with average pain intensity.

TABLE 1.

Descriptive statistics and zero-order correlations among variables (n=67)

1 2 3 4 5 6 7 8 9 10
1. NRS-IN 47.6±23.0
2. FPQ-III 0.412** 81.6±15.0
3. ASI 0.306* 0.392** 33.1±8.8
4. PASS-AVO 0.189 0.351** 0.319** 9.72±5.39
5. PCS 0.101 0.088 0.250* 0.503** 18.2±11.3
6. TAS-20 0.367** 0.065 0.257* 0.156 0.277* 46.6±10.8
7. TAS-F1 0.278* 0.045 0.348** 0.163 0.429** 0.788** 14.76±5.02
8. TAS-F2 0.311* −0.017 0.120 −0.012 0.130 0.868** 0.612** 12.98±4.41
9. TAS-F3 0.266* 0.121 0.111 0.205 0.057 0.670** 0.175 0.422** 18.90±4.50
10. SEX 0.197 −0.240 0.167 −0.026 −0.001 0.133 0.079 −0.019 0.249* 0.34

SEX is a coded variable (0 = female, 1 = male). Means ± SDs are reported on the diagonal.

*

P<0.05;

**

P<0.01. ASI Total score on the Anxiety Sensitivity Index; FPQ-III Total score on the Fear of Pain Questionnaire III; NRS-IN Numerical rating scale, pain intensity (0 to 100); PASS-AVO: Total score on the Avoidance subscale of the Pain Anxiety Symptoms Scale-20; PCS Total score on the Pain Catastrophizing Scale; TAS-20 Total score on the Toronto Alexithymia Scale-20; TAS-F1 Total score on the difficulty identifying feelings subscale of the TAS-20; TAS-F2 Total score on the difficulty describing feelings subscale of the TAS-20; TAS-F3 Total score on the externally oriented thinking subscale of the TAS-20

Relationship between alexithymia and average pain intensity after controlling for anxiety sensitivity, pain avoidance, fear of pain, pain catastrophizing, and sex

A two-step multiple linear regression analysis was used to test the relative contribution of alexithymia in predicting average pain intensity after controlling for sex and some of the factors in Turk’s diathesis-stress model of chronic pain and disability. Results of the analyses are presented in Table 2.

TABLE 2.

Multiple regression analysis for predictors of mean pain intensity (n=67)

Variable Beta P Total R2 R2Δ
Step 1

Model 1: Components of Turk model

Summary 0.270 0.270 4.502
FPQ-III 0.454 0.001
ASI 0.069 0.593
PASS-AVO −0.009 0.946
PCS 0.049 0.706
Sex 0.294 0.015
Step 2: After controlling for components of Turk model

Model 2A: Alexithymia

Final model 0.352 0.083 7.642
FPQ-III 0.453 0.001
ASI 0.012 0.922
PASS-AVO −0.002 0.987
PCS −0.025 0.841
Sex 0.263 0.023
TAS-20 0.307 0.008
Model 2b-1: TAS-F1 – Difficulty identifying feelings

Final model 0.319 0.049 4.333
FPQ-III 0.472 0.001
ASI −0.010 0.940
PASS-AVO 0.022 0.867
PCS −0.060 0.663
Sex 0.292 0.014
TAS-F1 0.259 0.042
Model 2b-2: TAS-F2 – Difficulty describing feelings

Final model 0.370 0.100 9.541
FPQ-III 0.475 0.000
ASI 0.019 0.876
PASS-AVO 0.030 0.818
PCS −0.002 0.987
Sex 0.315 0.006
TAS-F2 0.324 0.003
Model 2b-3: TAS-F3 – Externally oriented thinking

Final model 0.289 0.019 1.612
FPQ-III 0.433 0.002
ASI 0.076 0.554
PASS-AVO −0.039 0.780
PCS 0.055 0.668
Sex 0.250 0.045
TAS-F3 0.148 0.209

Sex coded as 0 (female) and 1 (male). ASI Anxiety Sensitivity Index; FPQ-III Fear of Pain Questionnaire III; PASS-AVO Avoidance subscale of the Pain Anxiety Symptom Scale-20; PCS Pain Catastrophizing Scale; TAS-20 Toronto Alexithymia Scale-20; TAS-F1 Total score on the difficulty identifying feelings subscale of the TAS-20; TAS-F2 Total score on the difficulty describing feelings subscale of the TAS-20; TAS-F3 Total score on the externally oriented thinking subscale of the TAS-20

First, fear of pain, anxiety sensitivity, pain avoidance, pain catastrophizing, and sex were entered in the regression analysis to create model 1. Results indicated that these five variables together accounted for 27% of the variance in average pain intensity (F[5, 61]=4.50; R2=0.27; P=0.001). Fear of pain (β=0.454; t=3.44; P=0.001), and sex (β=0.294; t=2.49; P=0.015) were the only significant predictors in model 1.

In model 2A, alexithymia was entered separately after controlling for variables in model 1. The overall model predicting average pain intensity was significant (F[6, 60]=5.43; R2=0.35; P=0.008). Alexithymia (β=0.31, t=2.76, P=0.008), fear of pain (β=0.45, t=3.61, P=0.001) and sex (β=0.26, t=2.33, P=0.023) were the only three significant predictors of average pain intensity. Fear of pain and sex accounted for 20.0% and 6.8% of the variance, respectively; alexithymia accounted for an additional 9.6% of unique variance.

Further analyses were conducted to determine which aspects of alexithymia accounted for the observed relationship with average pain intensity. A series of three linear regression analyses were conducted. Each of the three subscales of the TAS-20 – difficulty identifying feelings (factor 1), difficulty describing feelings (factor 2), and externally oriented thinking (factor 3) – was entered in three separate models after controlling for variables in model 1. Results of these analyses are presented in Table 2. For all three models, the overall model predicting average pain intensity was significant (Factor 1: F[6, 60]=4.68, R2=0.32, P=0.001; Factor 2: F[6, 60]=5.87, R2=0.37, P<0.001; Factor 3: F[6, 60]=4.06, R2=0.29, P=0.002). In model 2B-1, fear of pain (β=0.47, t=3.66, P=0.001), sex (β=0.29, t=2.54, P=0.014), and difficulty identifying feelings (β=0.26, t=2.08, P=0.042) were the only significant predictors of average pain intensity. In model 2B-2, fear of pain (β=0.48, t=3.83, P<0.001), sex (β=0.31, t=2.84, P=0.006) and difficulty describing feelings (β=0.32, t=3.09, P=0.003) were the only significant predictors of average pain intensity. In model 2B-3, fear of pain (β=0.43, t=3.27, P=0.002) and sex (β=0.25, t=2.04, P=0.045) were the only two predictors of average pain intensity. The externally oriented thinking subscale did not significantly predict average pain intensity (β=0.15, t=1.27, P=0.209).

Examining possible interactions among significant predictors of pain intensity

To examine whether fear of pain and alexithymia interacted to predict average pain intensity, a linear regression model was constructed that included the two variables and their interaction (multiplying the two variables after centering). The overall model significantly predicted average pain intensity (F[3, 63]=8.44; R2=0.29; P<0.001). Fear of pain (β=0.39, t =3.58, P=0.001) and alexithymia (β=0.35, t=3.12, P=0.003) significantly predicted average pain intensity but the fear of pain × alexithymia interaction did not (β=−0.02, t =−0.18, P=0.86), which suggests alexithymia and fear of pain are independent predictors of average pain intensity.

Similar analyses were conducted to examine whether fear of pain and alexithymia interacted with sex to predict average pain intensity. A linear regression model was constructed to include fear of pain, alexithymia, and sex, as well as the interactions between fear of pain and sex, and alexithymia and sex. The overall model significantly predicted average pain intensity (F[5, 61]=7.05; R2=0.37; P<0.001). Fear of pain (β=0.55, t=4.14, P<0.001), sex (β=0.25, t=2.30, P=0.025) and alexithymia (β=0.35, t=2.72, P=0.008) significantly predicted average pain intensity but the interactions between fear of pain and sex (β=−0.15, t=−1.07, P=0.290) and alexithymia and sex (β=−0.04, t=−0.29, P=0.774) did not.

DISCUSSION

The purpose of the present study was to investigate what role, if any, alexithymia plays in predicting pain intensity ratings, relative to fear- and anxiety-based constructs outlined in Turk’s diathesis-stress model (24) and commonly assessed in the pain literature. The results indicate pain catastrophizing, anxiety sensitivity, pain avoidance, fear of pain, and alexithymia accounted for 35% of the variance in average heat pain ratings. Fear of pain, sex, and alexithymia were the only significant predictors in the final regression model, accounting for 20.0%, 6.8%, and 9.6% of unique variance, respectively. Follow-up analyses failed to find a significant interaction between fear of pain and alexithymia, or between sex and fear of pain, or sex and alexithymia, indicating that these variables independently predict heat pain ratings. Additional analyses found the difficulty identifying feelings and difficulty describing feelings subscales of the TAS-20 were significant predictors of average heat pain ratings, while the externally oriented thinking subscale was not.

The present study is the first to measure both fear of pain and alexithymia in participants undergoing heat pain stimulation. The results are consistent with previous research examining the relationships between pain and fear of pain, and pain and alexithymia. Research has shown a significant positive correlation between alexithymia and pain ratings in healthy subjects during medical procedures (8,49) and in response to experimentally induced pain (7,9). Alexithymia has also been shown to correlate positively with pain severity, after controlling for depressed mood, in patients with painful temporomandibular disorder (50). Research also demonstrates a significant association between the minor pain subscale of the FPQ-III and pain intensity scores during an ischemic pain test, as well as an association between FPQ-III total scores and pain tolerance during electrical stimulation and thermal pain testing (51). High fear of pain, as measured by a Dutch version of the FPQ, has also been associated with increased cold pressor pain ratings (52).

The results of the present study indicate both fear of pain and alexithymia predict pain intensity ratings to thermal stimuli between 46°C and 49°C. Numerous studies have documented a link between alexithymia and over-reporting of physical symptoms (10), as well as physical illness, including chronic pain (50,53,54). Lumley et al (55) suggest individuals with alexithymia may experience physiological hyperarousal and a biased perception and reporting of somatic sensations, leading to increased physical illness. Alexithymia correlates significantly with measures of somatosensory amplification (56,57), lower tolerance to painful electrical stimulation (7), and is associated with higher baseline levels of sympathetic activity (55). In the present study, individuals with higher scores on the TAS-20 may have had a tendency to be excessively aware of or attentive to their bodies, relative to individuals with lower scores, resulting in amplified pain experiences and/or pain ratings in response to the unpleasant thermal stimulation. It is also possible, however, that individuals with higher TAS-20 scores have lower thresholds to painful stimuli reflecting a difference at an earlier phase of sensory processing (eg, at the spinal cord level). Future research may consider using the nociceptive flexion reflex paradigm (58) to help distinguish between these two possibilities. The nonsignificant interactions between sex and fear of pain and sex and alexithymia suggest that the influence of the latter two on pain intensity ratings was not due to a sex effect.

Hypervigilance to bodily sensations may also account for the relationship observed between fear of pain scores and heat pain ratings. Fear-avoidance models of chronic pain suggest that individuals who interpret pain as threatening may experience increased fear of pain, which may, in turn, promote a hypervigilance to body sensations, among other responses such as avoidance and guarding behaviours (39,59).

Interestingly, pain catastrophizing, pain avoidance, and anxiety sensitivity were not significant predictors of heat pain intensity ratings in the present study. One possible explanation for the lack of a significant association between catastrophizing and pain ratings is that catastrophizing, as measured by the PCS, may differ from actual catastrophizing experienced during experimental pain testing. Studies examining the administration of a standardized questionnaire, such as the PCS, and measures of catastrophizing in vivo during pain testing have found only a moderate correlation between in vivo catastrophizing and PCS scores (r=0.46). Moreover, only in vivo catastrophizing, and not PCS scores, correlated with cold pressor pain ratings and pain tolerance (49,60).

The lack of a significant association between pain avoidance and average pain intensity suggests pain avoidance responses, as measured by the PASS-AVO, which was designed to measure avoidance in the context of chronic pain, may not generalize to avoidance behaviours in the context of acute experimental pain. Anxiety sensitivity also did not have a significant direct effect on heat pain ratings. However, this does not rule out the possibility that anxiety sensitivity had an indirect effect on pain ratings through its relationship with alexithymia and/or fear of pain. Anxiety sensitivity has been shown to correlate with higher sensory pain ratings in experimental settings (6163), as well as with fear of pain (14,38,6466) and alexithymia (67,68).

It is important to note that the present study had a limited number of participants (n=7) with alexithymia scores in the clinical range. Therefore, caution should be taken in generalizing the present results to individuals with alexithymia. Furthermore, the present study focused on pain-free undergraduate university students; the relationships between alexithymia and the variables in Turk’s diathesis-stress model may differ in individuals with chronic pain. Future research exploring the relationships among fear of pain, alexithymia, and pain perception in individuals with clinical levels of alexithymia and/or chronic pain will help further elucidate the relationship among these variables.

SUMMARY

Individuals who fear pain or have difficulty describing and identifying emotions reported greater pain intensity to thermal stimulation. These findings add to the growing body of literature linking alexithymia to pain and suggest that difficulties with emotion regulation, either through reduced emotional awareness via alexithymia or heightened emotional awareness via fear of pain, may negatively impact the pain experience.

Acknowledgments

The present study was supported in part by infrastructure grants from the Canadian Foundation for Innovation and the Ontario Innovation Trust. JK is supported by a Canadian Institutes of Health Research (CIHR) Canada Research Chair in Health Psychology at York University. MGP is supported by a CIHR Canada Graduate Masters Award. ALM is supported by a CIHR Doctoral Award. MGP and ALM are Strategic Training Fellows in Pain: Molecules to Community.

REFERENCES

  • 1.Haviland MG, Hendryx MS, Cummings MA, Shaw DG, MacMurray JP. Multidimensionality and state dependency of alexithymia in recently sober alcoholics. J Nerv Ment Dis. 1991;179:284–90. doi: 10.1097/00005053-199105000-00007. [DOI] [PubMed] [Google Scholar]
  • 2.Hendryx MS, Haviland MG, Shaw DG. Dimensions of alexithymia and their relationships to anxiety and depression. J Pers Assess. 1991;56:227–37. doi: 10.1207/s15327752jpa5602_4. [DOI] [PubMed] [Google Scholar]
  • 3.Taylor GJ, Bagby RM, Parker JD. The alexithymia construct. A potential paradigm for psychosomatic medicine. Psychosomatics. 1991;32:153–64. doi: 10.1016/s0033-3182(91)72086-0. [DOI] [PubMed] [Google Scholar]
  • 4.Nemiah JC, Freyberger H, Sifneos PE. Alexithymia: A view of the psychosomatic process. In: Hill OW, editor. Modern Trends in Psychosomatic Medicine. London: Butterworths; 1976. pp. 430–9. [Google Scholar]
  • 5.Salminen JK, Saarijärvi S, Äärelä E. Two decades of alexithymia. J Psychosom Res. 1995;39:803–7. doi: 10.1016/0022-3999(95)00153-x. [DOI] [PubMed] [Google Scholar]
  • 6.Kreitler S, Niv D. Pain and alexithymia: The nature of a relation. The Pain Clinic. 2001;13:13–38. [Google Scholar]
  • 7.Nyklicek I, Vingerhoets AJ. Alexithymia is associated with low tolerance to experimental painful stimulation. Pain. 2000;85:471–5. doi: 10.1016/S0304-3959(99)00295-X. [DOI] [PubMed] [Google Scholar]
  • 8.Putterman E, Byrne N, Ditto B. Alexithymia and symptom reporting following blood donation. Psychosom Med. 2001;63:138–9. doi: 10.1097/01.psy.0000160471.66399.12. [DOI] [PubMed] [Google Scholar]
  • 9.Sivik T. Alexithymia and hypersensitivity to touch and palpation. Integr Psychol Behav Sci. 1993;28:130–6. doi: 10.1007/BF02691215. [DOI] [PubMed] [Google Scholar]
  • 10.Byrne N, Ditto B. Alexithymia, cardiovascular reactivity, and symptom reporting during blood donation. Psychosom Med. 2005;67:471–5. doi: 10.1097/01.psy.0000160471.66399.12. [DOI] [PubMed] [Google Scholar]
  • 11.Asmundson GJG, Norton PJ, Vlaeyen JWS. Fear-avoidance models of chronic pain: An overview. In: Asmundson GJG, Vlaeyen WS, Crombez G, editors. Understanding and Treating Fear of Pain. New York: Oxford University Press Inc; 2004. pp. 3–24. [Google Scholar]
  • 12.Melzack R. From the gate to the neuromatrix. Pain. 1999;(Suppl 6):S121–6. doi: 10.1016/S0304-3959(99)00145-1. [DOI] [PubMed] [Google Scholar]
  • 13.Merskey H, Bogduk N. Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms. 2nd edn. IASP Press; 1994. [Google Scholar]
  • 14.Asmundson GJG, Norton GR. Anxiety sensitivity in patients with physically unexplained chronic back pain: A preliminary report. Behav Res Ther. 1995;33:771–7. doi: 10.1016/0005-7967(95)00012-m. [DOI] [PubMed] [Google Scholar]
  • 15.Klages U, Kianifard S, Ulusoy O, Wehrbein H. Anxiety sensitivity as predictor of pain in patients undergoing restorative dental procedures. Community Dent Oral Epidemiol. 2006;34:139–45. doi: 10.1111/j.1600-0528.2006.00265.x. [DOI] [PubMed] [Google Scholar]
  • 16.Fritz JM, George SZ. Identifying psychosocial variables in patients with acute work-related low back pain: The importance of fear-avoidance beliefs. Phys Ther. 2002;82:973–83. [PubMed] [Google Scholar]
  • 17.Klenerman L, Slade PD, Stanley IM, et al. The prediction of chronicity in patients with an acute attack of low back pain in a general practice setting. Spine. 1995;20:478–84. doi: 10.1097/00007632-199502001-00012. [DOI] [PubMed] [Google Scholar]
  • 18.Linton SJ. A review of psychological risk factors in back and neck pain. Spine. 2000;25:1148–56. doi: 10.1097/00007632-200005010-00017. [DOI] [PubMed] [Google Scholar]
  • 19.Roelofs J, Peters ML, Patijn J, Schouten EGW, Vlaeyen JWS. Electronic diary assessment of pain-related fear, attention to pain, and pain intensity in chronic low back pain patients. Pain. 2004;112:335–42. doi: 10.1016/j.pain.2004.09.016. [DOI] [PubMed] [Google Scholar]
  • 20.Samwel HJ, Kraaimaat FW, Crul BJ, Evers AW. The role of fear-avoidance and helplessness in explaining functional disability in chronic pain: A prospective study. Int J Behav Med. 2007;14:237–41. doi: 10.1007/BF03002998. [DOI] [PubMed] [Google Scholar]
  • 21.Woby SR, Watson PJ, Roach NK, Urmston M. Are changes in fear-avoidance beliefs, catastrophizing, and appraisals of control, predictive of changes in chronic low back pain and disability? Eur J Pain. 2004;8:201–10. doi: 10.1016/j.ejpain.2003.08.002. [DOI] [PubMed] [Google Scholar]
  • 22.Granot M, Ferber SG. The roles of pain catastrophizing and anxiety in the prediction of postoperative pain intensity: A prospective study. Clin J Pain. 2005;21:439–45. doi: 10.1097/01.ajp.0000135236.12705.2d. [DOI] [PubMed] [Google Scholar]
  • 23.Severeijns RMS, Vlaeyen JWSPD, van den Hout MAPD, Weber WEJPD. Pain catastrophizing predicts pain intensity, disability, and psychological distress independent of the level of physical impairment. Clin J Pain. 2001;17:165–72. doi: 10.1097/00002508-200106000-00009. [DOI] [PubMed] [Google Scholar]
  • 24.Turk DC. A diathesis-stress model of chronic pain and disability following traumatic injury. Pain Res Manage. 2002;7:9–19. doi: 10.1155/2002/252904. [DOI] [PubMed] [Google Scholar]
  • 25.Leeuw M, Goossens M, Linton S, Crombez G, Boersma K, Vlaeyen J. The fear-avoidance model of musculoskeletal pain: Current state of scientific evidence. J Behav Med. 2007;30:77–94. doi: 10.1007/s10865-006-9085-0. [DOI] [PubMed] [Google Scholar]
  • 26.Lumley MA, Smith JA, Longo DJ. The relationship of alexithymia to pain severity and impairment among patients with chronic myofascial pain: Comparisons with self-efficacy, catastrophizing, and depression. J Psychosom Res. 2002;53:823–30. doi: 10.1016/s0022-3999(02)00337-9. [DOI] [PubMed] [Google Scholar]
  • 27.Watson PJ, Latif RK, Rowbotham DJ. Ethnic differences in thermal pain responses: A comparison of South Asian and White British healthy males. Pain. 2005;118:194–200. doi: 10.1016/j.pain.2005.08.010. [DOI] [PubMed] [Google Scholar]
  • 28.Reiss S, Peterson RA, Gursky DM, McNally RJ. Anxiety sensitivity, anxiety frequency and the prediction of fearfulness. Behav Res Ther. 1986;24:1–8. doi: 10.1016/0005-7967(86)90143-9. [DOI] [PubMed] [Google Scholar]
  • 29.Zinbarg RE, Barlow DH, Brown TA. Hierarchical structure and general factor saturation of the Anxiety Sensitivity Index: Evidence and implications. Psychol Assess. 1997;9:277–84. [Google Scholar]
  • 30.Rodriguez BF, Bruce SE, Pagano ME, Spencer MA, Keller MB. Factor structure and stability of the Anxiety Sensitivity Index in a longitudinal study of anxiety disorder patients. Behav Res Ther. 2004;42:79–91. doi: 10.1016/s0005-7967(03)00074-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Keefe FJ, Brown GK, Wallston KA, Caldwell DS. Coping with rheumatoid arthritis pain: Catastrophizing as a maladaptive strategy. Pain. 1989;37:51–6. doi: 10.1016/0304-3959(89)90152-8. [DOI] [PubMed] [Google Scholar]
  • 32.Sullivan MJ, Thorn B, Haythornthwaite JA, et al. Theoretical perspectives on the relation between catastrophizing and pain. Clin J Pain. 2001;17:52–64. doi: 10.1097/00002508-200103000-00008. [DOI] [PubMed] [Google Scholar]
  • 33.Sullivan MJL, Bishop SR, Pivik J. The pain catastrophizing scale: Development and validation. Psychol Assess. 1995;7:524–32. [Google Scholar]
  • 34.Osman A, Barrios FX, Gutierrez PM, Kopper BA, Merrifield T, Grittmann L. The Pain Catastrophizing Scale: Further psychometric evaluation with adult samples. J Behav Med. 2000;23:351–65. doi: 10.1023/a:1005548801037. [DOI] [PubMed] [Google Scholar]
  • 35.McCracken LM, Dhingra L. A short version of the Pain Anxiety Symptoms Scale (PASS-20): Preliminary development and validity. Pain Res Manage. 2002;7:45–50. doi: 10.1155/2002/517163. [DOI] [PubMed] [Google Scholar]
  • 36.McCracken LM, Zayfert C, Gross RT. The pain anxiety symptoms scale: Development and validation of a scale to measure fear of pain. Pain. 1992;50:67–73. doi: 10.1016/0304-3959(92)90113-P. [DOI] [PubMed] [Google Scholar]
  • 37.Abrams MP, Carleton RN, Asmundson GJ. An exploration of the psychometric properties of the PASS-20 with a nonclinical sample. J Pain. 2007;8:879–86. doi: 10.1016/j.jpain.2007.06.004. [DOI] [PubMed] [Google Scholar]
  • 38.Asmundson GJG, Taylor S. Role of anxiety sensitivity in pain-related fear and avoidance. J Behav Med. 1996;19:577–86. doi: 10.1007/BF01904905. [DOI] [PubMed] [Google Scholar]
  • 39.Norton PJ, Asmundson GJG. Amending the fear-avoidance model of chronic pain: What is the role of physiological arousal? Behav Ther. 2003;34:17–30. [Google Scholar]
  • 40.McNeil DW, Rainwater AJ. Development of the Fear of Pain Questionnaire-III. J Behav Med. 1998;21:389–410. doi: 10.1023/a:1018782831217. [DOI] [PubMed] [Google Scholar]
  • 41.Taylor GJ, Bagby RM. New trends in alexithymia research. Psychother Psychosom. 2004;73:68–77. doi: 10.1159/000075537. [DOI] [PubMed] [Google Scholar]
  • 42.Bagby RM, Parker JDA, Taylor GJ. The twenty-item Toronto Alexithymia Scale-I. Item selection and cross-validation of the factor structure. J Psychosom Res. 1994;38:23–32. doi: 10.1016/0022-3999(94)90005-1. [DOI] [PubMed] [Google Scholar]
  • 43.Parker JDA, Taylor GJ, Bagby RM. The 20-Item Toronto Alexithymia Scale: III. Reliability and factorial validity in a community population. J Psychosom Res. 2003;55:269–75. doi: 10.1016/s0022-3999(02)00578-0. [DOI] [PubMed] [Google Scholar]
  • 44.Katz J, Melzack R. Measurement of pain. Surg Clin North Am. 1999;79:231–52. doi: 10.1016/s0039-6109(05)70381-9. [DOI] [PubMed] [Google Scholar]
  • 45.Bijur PE, Latimer CT, Gallagher EJ. Validation of a verbally administered Numerical Rating Scale of acute pain for use in the emergency department. Acad Emerg Med. 2003;10:390–2. doi: 10.1111/j.1553-2712.2003.tb01355.x. [DOI] [PubMed] [Google Scholar]
  • 46.Williamson A, Hoggart B. Pain: A review of three commonly used pain rating scales. J Clin Nurs. 2005;14:798–804. doi: 10.1111/j.1365-2702.2005.01121.x. [DOI] [PubMed] [Google Scholar]
  • 47.Taylor GJ. The alexithymia construct: Conceptualization, validation, and relationship with basic dimensions of personality. New Trends Exp Clin Psychiatry. 1994;10:61–74. [Google Scholar]
  • 48.Schmidt NB, Joiner TE. Structure of the Anxiety Sensitivity Index psychometrics and factor structure in a community sample. J Anxiety Disord. 2002;16:33–49. doi: 10.1016/s0887-6185(01)00087-1. [DOI] [PubMed] [Google Scholar]
  • 49.Dixon KE, Thorn BE, Ward LC. An evaluation of sex differences in psychological and physiological responses to experimentally-induced pain: A path analytic description. Pain. 2004;112:188–96. doi: 10.1016/j.pain.2004.08.017. [DOI] [PubMed] [Google Scholar]
  • 50.Glaros AG, Lumley MA. Alexithymia and pain in temporomandibular disorder. J Psychosom Res. 2005;59:85–8. doi: 10.1016/j.jpsychores.2005.05.007. [DOI] [PubMed] [Google Scholar]
  • 51.Roelofs J, Peters ML, Deutz J, Spijker C, Vlaeyen JWS. The Fear of Pain Questionnaire (FPQ): Further psychometric examination in a non-clinical sample. Pain. 2005;116:339–46. doi: 10.1016/j.pain.2005.05.003. [DOI] [PubMed] [Google Scholar]
  • 52.Roelofs J, Peters ML, van der Zijden M, Vlaeyen JWS. Does fear of pain moderate the effects of sensory focusing and distraction on cold pressor pain in pain-free individuals? J Pain. 2004;5:250–6. doi: 10.1016/j.jpain.2004.04.001. [DOI] [PubMed] [Google Scholar]
  • 53.Lumley MA, Asselin LA, Norman S. Alexithymia in chronic pain patients. Compr Psychiatry. 1997;38:160–5. doi: 10.1016/s0010-440x(97)90069-9. [DOI] [PubMed] [Google Scholar]
  • 54.Mehling WE, Krause N. Are difficulties perceiving and expressing emotions associated with low-back pain? The relationship between lack of emotional awareness (alexithymia) and 12-month prevalence of low-back pain in 1180 urban transit operators. J Psychosom Res. 2005;58:73–81. doi: 10.1016/j.jpsychores.2004.05.007. [DOI] [PubMed] [Google Scholar]
  • 55.Lumley MA, Stettner L, Wehmer F. How are alexithymia and physical illness linked? A review and critique of pathways. J Psychosom Res. 1996;41:505–18. doi: 10.1016/s0022-3999(96)00222-x. [DOI] [PubMed] [Google Scholar]
  • 56.Nakao M, Barsky AJ, Kumano H, Kuboki T. Relationship between somatosensory amplification and alexithymia in a Japanese psychosomatic clinic. Psychosomatics. 2002;43:55–60. doi: 10.1176/appi.psy.43.1.55. [DOI] [PubMed] [Google Scholar]
  • 57.Wise TN, Mann LS. The relationship between somatosensory amplification, alexithymia, and neuroticism. J Psychosom Res. 1994;38:515–21. doi: 10.1016/0022-3999(94)90048-5. [DOI] [PubMed] [Google Scholar]
  • 58.France CR, France JL, al’Absi M, Ring C, McIntyre D. Catastrophizing is related to pain ratings, but not nociceptive flexion reflex threshold. Pain. 2002;99:459–63. doi: 10.1016/s0304-3959(02)00235-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Vlaeyen JWS, Linton SJ. Fear-avoidance and its consequences in chronic musculoskeletal pain: A state of the art. Pain. 2000;85:317–32. doi: 10.1016/S0304-3959(99)00242-0. [DOI] [PubMed] [Google Scholar]
  • 60.Edwards RR, Campbell CM, Fillingim RB. Catastrophizing and experimental pain sensitivity: Only in vivo reports of catastrophic cognitions correlate with pain responses. J Pain. 2005;6:338–9. doi: 10.1016/j.jpain.2005.02.013. [DOI] [PubMed] [Google Scholar]
  • 61.Jones A, Zachariae R. Investigation of the interactive effects of gender and psychological factors on pain response. Br J Health Psychol. 2004;9:405–18. doi: 10.1348/1359107041557101. [DOI] [PubMed] [Google Scholar]
  • 62.Keogh E, Birkby J. The effect of anxiety sensitivity and gender on the experience of pain. Cogn Emot. 1999;13:813–29. [Google Scholar]
  • 63.Keogh E, Cochrane M. Anxiety sensitivity, cognitive biases, and the experience of pain. J Pain. 2002;3:320–9. doi: 10.1054/jpai.2002.125182. [DOI] [PubMed] [Google Scholar]
  • 64.Martin AL, McGrath PA, Brown SC, Katz J. Anxiety sensitivity, fear of pain and pain-related disability in children and adolescents with chronic pain. Pain Res Manage. 2007;12:267–72. doi: 10.1155/2007/897395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Muris P, Vlaeyen J, Meesters C. The relationship between anxiety sensitivity and fear of pain in healthy adolescents. Behav Res Ther. 2001;39:1357–68. doi: 10.1016/s0005-7967(01)00018-3. [DOI] [PubMed] [Google Scholar]
  • 66.Zvolensky MJ, Goodie JL, McNeil DW, Sperry JA, Sorrell JT. Anxiety sensitivity in the prediction of pain-related fear and anxiety in a heterogeneous chronic pain population. Behav Res Ther. 2001;39:683–96. doi: 10.1016/s0005-7967(00)00049-8. [DOI] [PubMed] [Google Scholar]
  • 67.Devine H, Stewart SH, Watt MC. Relations between anxiety sensitivity and dimensions of alexithymia in a young adult sample – theory, research, and treatment of the fear of anxiety. J Psychosom Res. 1999;47:145–58. doi: 10.1016/s0022-3999(99)00033-1. [DOI] [PubMed] [Google Scholar]
  • 68.Mueller J, Alpers GW. Two facets of being bothered by bodily sensations: Anxiety sensitivity and alexithymia in psychosomatic patients. Compr Psychiatry. 2006;47:489–95. doi: 10.1016/j.comppsych.2006.03.001. [DOI] [PubMed] [Google Scholar]

Articles from Pain Research & Management : The Journal of the Canadian Pain Society are provided here courtesy of Wiley

RESOURCES